RedHill Biopharma Ltd Announces RDHL Opaganib Selected by NIH RNCP For Development

RedHill's Opaganib Selected by the NIH Radiation and Nuclear Countermeasures ProgramThe National Institutes of Health's (NIH) Radiation and Nuclear Countermeasures Program (RNCP) has selected opaganib for testing via their radiation medical …